Years Active: 2025
Title: Michael Raymond Cary: Innovator in Pharmaceutical Aqueous Therapeutic Particles
Introduction
Michael Raymond Cary is an accomplished inventor based in Lexington, SC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of aqueous therapeutic particles. His innovative approach has the potential to enhance the bioavailability of various therapeutic substances.
Latest Patents
Cary holds a patent for a process titled "Process for making aqueous therapeutic particle having stable exterior water clustering with nanosized thickness." This invention focuses on creating pharmaceutical aqueous therapeutic particles (AQTP) with stable exterior water clustering that has a nanosized thickness of less than 300 nanometers. The AQTP developed through this process demonstrates improved bioavailability when administered to mammals compared to conventional pharmaceutical drug particles.
Career Highlights
Throughout his career, Cary has been dedicated to advancing pharmaceutical technologies. His patented process includes an improved apparatus that is computer-controlled and capable of continuous operation with high efficiency. This innovation allows for the consistent production of AQTP, surpassing the capabilities of previous prototype apparatuses.
Collaborations
Cary has collaborated with notable individuals in his field, including Karl P Dresdner, Jr and Chase Hudson. These partnerships have contributed to the refinement and success of his innovative processes.
Conclusion
Michael Raymond Cary's work in the development of aqueous therapeutic particles represents a significant advancement in pharmaceutical technology. His innovative processes and collaborations continue to pave the way for improved therapeutic applications.